StockComparison Logo
vs

BIO-B vs CORT

Comparison between Bio-Rad Laboratories Inc - Class B (BIO-B, Company) and Corcept Therapeutics Inc (CORT, Company).

Both BIO-B and CORT are from the Healthcare sector.

5-Year PerformanceCORT has outperformed BIO-B, delivering a return of +30.5% compared to -12.1%

BIO-B vs CORT - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
BIO-B
$8.20B
CORT
$8.16B
Max Drawdown
Winner
BIO-B
72.48%
CORT
94.28%
Sharpe Ratio
Winner
BIO-B
0.63
CORT
0.62
5Y Beta
Winner
BIO-B
-0.11
CORT
1.32
Industry
BIO-B
Medical Devices
CORT
Biotechnology
P/E Ratio
Winner
BIO-B
-16.63
CORT
185.65
Forward P/E
Winner
BIO-B
34.36
CORT
102.04
PEG Ratio
BIO-B
1.21
Winner
CORT
0.81
5Y EPS CAGR
BIO-B
N/A
CORT
-8.23%
Debt to Equity
BIO-B
11.72%
Winner
CORT
0.00%
Free Cash Flow Yield
Winner
BIO-B
4.36%
CORT
1.47%
P/S Ratio
Winner
BIO-B
3.14
CORT
10.82
P/B Ratio
Winner
BIO-B
1.19
CORT
12.22

BIO-B vs CORT - Historical Returns

Returns include dividend reinvestment.

1M
BIO-B
+16.58%
Winner
CORT
+47.45%
3M
BIO-B
+13.26%
Winner
CORT
+158.30%
6M
Winner
BIO-B
-2.11%
CORT
-4.79%
1Y
Winner
BIO-B
+21.62%
CORT
+17.24%
5Y(CAGR)
BIO-B
-12.10%
Winner
CORT
+30.54%
10Y(CAGR)
BIO-B
+7.51%
Winner
CORT
+31.42%
Max(CAGR)
Winner
BIO-B
+13.05%
CORT
+9.03%

BIO-B vs CORT - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearBIO-BCORT
2026-2.11%+117.59%
2025-4.58%-30.36%
2024+1.54%+108.57%
2023-20.76%+61.03%
2022-44.94%-0.15%
2021+25.91%-24.11%
2020+54.89%+116.92%
2019+60.70%-12.45%
2018-3.46%-26.35%
2017+30.08%+145.38%
2016+33.03%+55.79%
2015+14.67%+59.62%
2014-2.37%-10.98%
2013+15.80%+116.89%
2012+6.31%-59.14%
2011-9.98%-13.64%
2010+6.86%+38.85%
2009+31.80%+105.93%
2008-30.83%-65.77%
2007+28.86%+157.50%
2006+28.31%-66.21%
2005+14.04%-39.97%
2004-2.64%-48.90%
2003+36.47%N/A
2002+32.81%N/A
2001+103.17%N/A
2000+36.25%N/A
1999-0.56%N/A

BIO-B vs CORT Drawdown Comparison

The maximum drawdown for BIO-B was -72.48%, occurring on Apr 9, 2025. This drawdown has not yet recovered.

The maximum drawdown for CORT was -94.28%, occurring on Oct 13, 2006. Recovery took 3303 trading sessions.

The current BIO-B drawdown is -62.85%. The current CORT drawdown is -27.23%.

RankBIO-BCORT
#1-72.48%
Sep 10, 2021 - Apr 9, 2025
-94.28%
Apr 14, 2004 - May 26, 2017
#2-50.14%
Aug 11, 2008 - Apr 20, 2010
-71.85%
Mar 31, 2025 - Mar 13, 2026
#3-35.34%
Mar 1, 2000 - Nov 29, 2000
-61.65%
Jan 29, 2018 - Dec 14, 2020
#4-34.33%
Jun 19, 2002 - May 20, 2003
-45.91%
Feb 8, 2021 - Aug 3, 2023
#5-31.86%
Sep 4, 2018 - Aug 2, 2019
-37.57%
Sep 14, 2023 - Jun 5, 2024
#6-31.00%
May 3, 2011 - Jan 9, 2014
-26.23%
Feb 13, 2025 - Mar 31, 2025
#7-27.68%
Nov 8, 2007 - Aug 11, 2008
-23.89%
Oct 5, 2017 - Jan 10, 2018
#8-25.78%
May 3, 2010 - Mar 7, 2011
-18.36%
Jun 6, 2024 - Jul 22, 2024
#9-23.33%
Dec 26, 2003 - Aug 2, 2005
-18.08%
Dec 4, 2024 - Jan 21, 2025
#10-22.65%
Feb 1, 2007 - Sep 27, 2007
-15.46%
Jun 7, 2017 - Jun 23, 2017
#11-20.71%
May 17, 2002 - Jun 17, 2002
-13.04%
Nov 8, 2024 - Dec 3, 2024
#12-19.75%
Feb 18, 2020 - Apr 14, 2020
-12.62%
Jul 31, 2024 - Sep 17, 2024
#13-19.59%
Jun 6, 2003 - Dec 26, 2003
-9.28%
Aug 7, 2017 - Aug 16, 2017
#14-18.74%
Feb 20, 2014 - Mar 12, 2015
-8.72%
Aug 16, 2017 - Aug 30, 2017
#15-18.70%
Nov 6, 2020 - Feb 12, 2021
-7.97%
May 26, 2017 - Jun 7, 2017

Correlation

Correlation between BIO-B and CORT is 0.48 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.48
-101

Select Stocks to Compare